OCT-Guided PCTA: Does It Offer any Benefits?

For many years, percutaneous transluminal coronary angioplasty (PCTA) has expanded significantly worldwide. However, despite the demonstrated advantages of intravascular ultrasound (IVUS) in terms of minimal luminal area, reduced cardiovascular events, and restenosis, its use is not very common due to various reasons.

ATC guiada por OCT

On the other hand, optical coherence tomography (OCT) offers even higher resolution than IVUS. While there are reports comparing it to angiography, we still lack randomized studies that compare it directly to angiography-guided percutaneous coronary intervention (AG-PCI).

The ILUMIEN IV: OPTIMAL PCI study is a large-scale prospective randomized study (1:1) that compared OCT-guided PCI (OCT-PCI) with angiography-guided PCI (AG-PCI). The study included a total of 1233 patients who underwent OCT-PCI and 1254 patients who underwent AG-PCI with the XIENCE stent.

There were two primary endpoints: the primary efficacy endpoint (PEP E), which referred to the final minimum stent area, and the primary clinical endpoint (PEP C), defined as target lesion failure (TLF) at 2 years, including cardiac death, myocardial infarction, or ischemia-driven target lesion revascularization.

Read also: TAVI-in-TAVI with Balloon-Expandable Valves.

Both patient groups were comparable in terms of characteristics. The average patient age was 65 years, and 78% of subjects were male; 72% had hypertension, 42% had diabetes, 22% had experienced an acute myocardial infarction (AMI), 13% had undergone a previous PCI, and 5% had undergone myocardial revascularization surgery (MRS). The estimated glomerular filtration rate (eGFR) was 79 mL/min, 2.2% of patients were on dialysis, and the ejection fraction was 55%.

Regarding clinical presentation, 14% of patients had silent ischemia, 28% had stable angina, 28% had unstable angina, 24% had non-ST-segment elevation myocardial infarction (NSTEMI), and 6% had recent ST-segment elevation myocardial infarction (STEMI). There were no significant differences in terms of medical treatment received.

Furthermore, there were no differences between the groups regarding predilation, the number of treated vessels, or the number of stents implanted. However, procedure time, fluoroscopy time, and contrast volume administered were slightly higher in the OCT-PCI group.

Read also: ROTA.shock Outcomes: Intravascular Lithotripsy vs. Rotational Atherectomy.

In terms of results, the PEP E favored the OCT-PCI group, with a minimum stent area of 5.72 ± 2.04 mm2 compared with 5.36 ± 1.87 mm2 in the AG-PCI group (mean difference = 0.36 mm2; 95% confidence interval [CI], 0.21 to 0.51; P <0.001). However, there were no significant differences in the PEP C (7.4% vs. 8.2%; hazard ratio, 0.90; 95% CI, 0.67 to 1.19; P = 0.45). There were also no differences in terms of cardiac death, myocardial infarction, or ischemia-driven target lesion revascularization.

Conclusion

Patients undergoing OCT-guided PCI had a significantly larger minimum stent area compared with those guided by angiography. However, there were no apparent differences in major cardiovascular events at 2 years (TLF).

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Optical Coherence Tomography–Guided versus Angiography-Guided PCI.

Reference: Ziad A. Ali, et al. NEJM DOI: 10.1056/NEJMoa2305861.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...